What is NDC 55150-299?

55150-299 is the product NDC for Fosaprepitant Dimeglumine, Fosaprepitant dimeglumine 150 mg/5mL injection, powder, lyophilized, for solution, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Fosaprepitant Dimeglumine?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Fosaprepitant Dimeglumine NDC 55150-299

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-299Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0299Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-299-01	5515002990155150029901	1 VIAL, SINGLE-DOSE in 1 CARTON (55150-299-01) / 5 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 12, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fosaprepitant Dimeglumine
Generic name (nonproprietary): fosaprepitant dimeglumine
Active ingredients: Fosaprepitant dimeglumine — 150 mg/5mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Eugia US LLCNDC labeler code 55150
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210625
Marketing start: Jan 12, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Neurokinin 1 Antagonists (Mechanism)
Identifiers: Product ID 55150-299_048f8975-d1ab-4d91-b819-552bc651c6efSPL ID 048f8975-d1ab-4d91-b819-552bc651c6ef
Pharmacologic class: Substance P/Neurokinin-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150029901 followed by a unit qualifier and the quantity

Package 55150-0299-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 55150-299

What is NDC 55150-299?: 55150-299 is the product NDC for Fosaprepitant Dimeglumine, Fosaprepitant dimeglumine 150 mg/5mL injection, powder, lyophilized, for solution, listed with the FDA by Eugia US LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Fosaprepitant Dimeglumine.
What is the active ingredient?: Fosaprepitant dimeglumine.
Who is the labeler?: Eugia US LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Fosaprepitant Dimeglumine?: 3 other product NDCs are listed under this name. See all Fosaprepitant Dimeglumine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Fosaprepitant Dimeglumine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Fosaprepitant Dimeglumine	Fosaprepitant dimeglumine 150 mg/5mL	Injection, Powder, Lyophilized, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9428	00143-9428-01
Fosaprepitant Dimeglumine	Fosaprepitant dimeglumine 150 mg/5mL	Injection, Powder, Lyophilized, For solutionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9384	00143-9384-01
Fosaprepitant Dimeglumine	Fosaprepitant dimeglumine 150 mg/5mL	Injection, Powder, Lyophilized, For solutionIntravenous	Qilu Pharmaceutical Co., Ltd.	67184-0540	67184-0540-01